Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imitatevir phosphate plus sofosbuvir in chronic hepatitis C genotype 1
CTR20170624Phase 2Completed
- Sponsor
- Guangdong Dongyangguang Pharmaceutical
- Start
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of imitatevir, sofosbuvir in chronic hepatitis C (CHC), sponsored by Guangdong Dongyangguang Pharmaceutical. Started Jun 2017; status: completed.
02
Drugs
imitatevirsofosbuvir
03
Conditions
chronic hepatitis C (CHC)
Beyond the preview
Go deeper on CTR20170624.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20170624.